Retinoids and vitamin D (VD) cooperate to induce the differenthey present a potential interest for differentiation therapy. The tiation and inhibit the proliferation of human myelomonocytic efficacy of RA in the treatment of acute promyelocytic leukeleukemia cells. Two classes of retinoids receptors, the RARs mia (APL) is now well established. 6, 7 Hypercalcemic effects of all-trans and 9-cis RA isomers, RXRs bind selectively 9-cis alone was significantly less potent than 9-cis RA, combinations
X receptors (RXRs), have been characterized (Refs 12, 13 and specific agonists (CD2608 and LGD1069), which also proved references therein). 12, 13 While RARs bind and respond to both able to cooperate with VD. Finally, while each synthetic agonist all-trans and 9-cis RA isomers, RXRs bind selectively 9-cis alone was significantly less potent than 9-cis RA, combinations RA.
14 of the RAR and RXR selective agonists TTNPB and LGD1069
A major advance was the finding that a diversity of nuclear appeared to be as effective as the pan agonist 9-cis-RA. These results confirm that various retinoids can cooperate with VD receptors, including the VDR and RARs themselves, preferenand demonstrate that, at a whole cell level, optimal effects tially bind to DNA as heterodimers with RXR as a common require the activation of both RAR and RXR receptors.
partner. 15, 16 Assuming that 9-cis RA may be formed endogenKeywords: retinoic acid; 1,25 dihydroxyvitamin D3; retinoid recepously by isomerization of the all-trans isomer, it could be tors; RAR and RXR agonists; myelomonocytic cell lines; differenspeculated that cooperative effects between retinoids and VD tiation result from the simultaneous activation of both partners in VDR/RXR heterodimers. In line with this hypothesis, we found that RXR␣ is expressed in myelomonocytic cells and that its Introduction expression is increased by VD treatment of leukemia cells. 17 The active hormonal form of vitamin D, 1,25-dihydroxy-VD 3 However, several experiments suggested that 9-cis RA might or 1,25-dihydroxycholecalciferol (VD) is involved in the connot be an activator of VDR/RXR and even that it could inhibit trol of hematopoiesis.
1,2 VD can be produced by activated the effect of VD by promoting the formation of RXR/RXR macrophages and influences several steps of monocytehomodimers at the expense of heterodimers. 18, 19 An alternamacrophage development.
2 Upon exposure to VD, the human tive hypothesis was, therefore, that RXR is merely a cofactor, myeloblastic pluripotent HL-60 and the monoblastic U937 RAR being the unique mediator of retinoids. In this respect, cell lines acquire macrophage-specific functions. 3 Metabolites we found that a selective RAR agonist, unable to activate RXR, of vitamin A such as all-trans retinoic acid (RA) also regulate significantly cooperated with VD in U937 cells. 20 In the several stages of hematopoiesis and influence the developpresent work, we studied the expression of RAR at the protein ment and functions of the immune system. 4 Cells of the monolevel using specific antibodies and we investigated its role in cyte-macrophage lineage respond to RA by phenotypic cell differentiation using receptor-specific synthetic agonists changes leading to the expression of phagocytic properties. 5 and antagonists. Our results clearly show that ligand-depenSince VD and RA, while inducing the differentiation of human dent activation of RAR␣ is actually involved in the myelomonocytic leukemia cells, also inhibit cell proliferation cooperation between RA and VD. However, these experiments also demonstrate that RXR behaves as a ligand-activable receptor in U937 cells, so that optimal synergistic effects are obtained by associating RAR-and RXR-specific ligands.
Materials and methods
Cell lines and assessment of cell differentiation 500 l RPMI were transferred in a counting tube filled with 500 l luminol 6 × 10 −6 m. The suspension was pre-warmed Cellular retinoids extracted with acetonitrile: butanol (1:1) were analyzed as previously described.
14 Radioactivity of at 37°C, before the addition of 50 l of 1 mg/ml zymosan opsonized with human serum, or of 2 × 10 −5 m fMLP. Light cellular extracts, culture media and HPLC effluents was determined by liquid scintillation counting and expressed as emission was then measured for 30 min at 15 s intervals (zymosan) or for 10 min at 5 s intervals (fMLP). d.p.m. Whole cell and nuclear extracts were prepared as previously described. 17 Proteins (70 g) were fractionated by SDS-PAGE on a 10% polyacrylamide gel and then electroblotted onto nitrocellulose filters using a semi-dry electroblotter (Millipore, St Quentin en Yvelines, France) at 0.8 mA/cm 2 for 1 h. The nitrocellulose filters were then blocked with 5% non-fat powdered milk in PBS and the RAR␣ protein was immunodetected by using a rabbit polyclonal antiserum RP␣(F) directed again the F region of RAR␣ (Ref. 23 and references therein). The filters were probed with peroxidase-labelled protein A (Amersham, Les Ulis, France) and the specific complexes were revealed by ECL-photochemiluminescence according to the manufacturer's protocol. Extracts from mouse RAR␣-transfected COS-1 cells (mRAR␣) were used as positive controls and were prepared as previously described. 23 The specificity of the bands was checked by depletion experiments using antibodies preincubated with the peptide used for immunization (data not shown). The optical densities of the bands obtained on the films were determined by densitometric analysis with a BioImage System (Millipore, Bedford, MA, USA). ( Figure 1a, lanes 1, 2, 4 and 6) . The larger amount of RAR␣ was found in THP-1 cells (Figure 1a, lane 6 ) and the lower level in U937 cells (Figure 1a, lane 2) .
of RARs in the differentiation process (Table 1) . We compared the effects of retinoids and VD on the three cell lines by measIn extracts from U937 cells (Figure 1b) , VD alone or in combination with RA caused an increased expression of RAR␣ uring the luminescence associated with phagocytosis of zymosan particles (Figure 2a) . These experiments showed that: within 24 h of treatment (Figure 1b lanes 6 and 9) , with no alterations of the electrophoretic pattern. By contrast, 
A RAR␣ antagonist inhibits the effects of retinoids
We used the RAR␣-specific antagonist Ro 41-5253 to block selectively the RAR pathway. 21, 25 The effects of the antagonist RAR agonists potentiate VD-induced monocytic differentiation on U937 cell differentiation were evaluated by monitoring oxidative responses elicited by fMLP and zymosan after 3 days of treatment (Figure 3 ). Ro 41-5253 was used at 1 m. At this Natural retinoids are unstable and rapidly isomerized. 24 When retinoids were extracted from culture medium or cell pellets concentration, it had itself no detectable effect on cell proliferation or differentiation parameters, whereas it inhibited all the after 8 h culture, HPLC analyses showed that up to 8% 9-cis RA were generated from all-trans 3 H RA (data not illustrated). effects of 10 nm 9-cis RA and all-trans RA alone (data not illustrated). The experiments showed that (1) VD induced We therefore used synthetic RAR-specific agonists (TTNPB or Ro 40-6055) instead of all-trans RA to assess the involvement fMLP responsiveness and an intense chemiluminescence in RXR and RAR agonists cooperate with VD to induce U937 cell differentiation
LGD1069 and CD2608 (Table 1) have been previously characterized as RXR-selective retinoids by cotransfection experiments and competitive binding assays.
LGD1069 was 10-fold more potent than CD2608 to activate RXR-dependent gene expression. 22 In order to assess the involvement of RXR in the RA/VD-induced differentiation process, U937 cells were treated with LGD1069 or CD2608 in association with VD alone or with VD plus TTNPB. The responses of cells to zymosan were assayed after 3 days of treatment. Doseresponse experiments showed that LGD1069 itself potentiated the action of VD. The effects of the RXR agonist were significantly increased in the presence of TTNPB (Figure 4a) . The lower activity of CD2608 compared to LGD1069 (Figure 4b ) was in agreement with previous data on the activities of the two molecules. 22 LGD1069 1 m potentiated the action of VD as efficiently as 0.1 m TTNPB and the combination of both agents at these concentrations gave similar effects as 0.1 m 9-cis RA (Figure 4c ).
Fetal calf serum (FCS) supplementing culture medium may contain retinoids, VD and other lipophilic substances, which may interfere with experimentally added differentiating agents. 26 We therefore compared the response of U937 cells maintained in FCS-containing medium to that of cells grown in a synthetic defined medium. These data (not illustrated) showed that: (1) similar synergistic effects between RA and VD were observed in both culture conditions; and (2) RXR agonists exhibited cooperative effects with VD at the same level as in complete medium thus allowing consideration that low amounts of serum endogeneous retinoids had no detectable influence on the activity per se of RXR agonists.
Discussion
In the present work, we studied the retinoid signaling path- changes and can thus be taken as fair indicators of differen-100 nm RA + 100 nm VD; () 100 nm 9-cis RA + 100 nm VD.
tiation.
9,27,28
Many effects of VD and retinoids are mediated by their nuclear receptors. These factors dimerize for efficient binding to DNA target sequences. Various combinations of homo-and heterodimerization between these receptors have been response to zymosan only if associated with retinoids ( Figure 3a and b, compare lane 1 to lanes 3, 5, 7 and 9); (2) Ro described 15, 16 suggesting multiple possibilities of cross-talk and interferences between hormonal pathways, such as com-41-5253 inhibited the effects of RA and RAR␣ agonists (Figure 3a and b, compare lanes 3, 7, 9 to lanes 4, 8, 10) ; and petition for a common dimerization partner or dual responsiveness of heterodimers to their activators. According to data (3) Ro 41-5253 reduced but not abrogated the cooperative effects between VD and 10 nm 9-cis RA and a synergy was derived from in vitro experiments, the effects of retinoids can be transduced by RAR/RXR heterodimers, RXR homodimers still observed between both agents (Figure 3a and b, compare lanes 5 to lanes 6). However, Ro 41-5253 completely or complexes between RXR and other members of the nuclear receptors superfamily, among them an increasing number of inhibited the potentiation of VD-induced differentiation by 1 nm 9-cis RA (data not illustrated).
orphan receptors. 15, 16 The expression of RAR␣ and RXR␣ in myelomonocytic cells was previously investigated at the this process, by forming either VDR/RAR or RAR/RXR heterodimers. 15, 32 mRNA level. 10, 29 Using specific antibodies, we have already shown that the RXR␣ protein is present in HL-60, U937 and
In the course of the present study, the fact that 9-cis RA, which is a ligand for both RARs and RXRs, appeared to be the THP-1 cell lines and that its expression is increased upon exposure to VD. 17 In the present study, immunoanalyses most efficient retinoid cooperating with VD, suggested that RXR is involved in U937 cell differentiation as a ligand-activrevealed the presence of the RAR␣ protein in the three cell lines. The fact that THP-1 cells express high amounts of RAR␣ able receptor. We found that an RAR␣ antagonist fully inhibited the synergy between VD and 1 nm 9-cis RA but only is in agreement with data showing that this cell line is highly sensitive to RA. 20, 27 The increased expression of RXR␣ and reduced the effects obtained with 10-fold higher concentration. Since 9-cis RA has a 100-fold higher affinity for RAR␣ RAR␣ in U937 cells upon VD treatment is probably one of the factors accounting for the synergy between VD and retinoids.
than for RXR␣, 33 such an observation might indicate that low concentrations of 9-cis RA activate mostly RAR␣, while higher In proliferating U937, HL-60 and THP-1 cells, the immunoreactive protein revealed by anti-RAR␣ antibodies displayed concentrations would activate RXR␣. An alternative explanation would be that the competition between Ro 41-5253 an electrophoretic mobility higher than the major species produced in transfected COS-1 cells. Wide variations of the RAR␣ and 9-cis RA for binding to RAR␣ favors the activator molecule at high concentrations. The fact that RXR may be ligandelectrophoretic pattern were observed following VD or RA plus VD treatments in HL-60 cells and THP-1 cells but not in activated in U937 cells was demonstrated using specific RXR agonists. These compounds cooperate moderately but signifi-U937 cells. In other cells and tissue extracts, such alterations have been correlated with phosphorylation of the receptor, cantly with VD to induce differentiation and their potency is related to their affinity for RXR. It must be stressed that their susceptible to modulate the DNA binding and transcriptional activities of RAR␣. 23 activity was still observed in culture conditions avoiding a possible involvement of serum retinoids and therefore in the The cooperation between VD and an RAR␣-specific agonist and its inhibition by an RAR␣-specific antagonist clearly demabsence of stimulation of the RAR pathway. The potentiation of VD activity by RXR-specific ligands is onstrated the involvement of RAR␣ in cell differentiation. The role of retinoid receptors in the granulocytic differentiation of somewhat surprising in the light of several data indicating that the activation of RXR can inhibit the activation of other sig-HL-60 cells was previously demonstrated. 30 Furthermore, in normal primary mouse bone marrow cells, the expression of naling pathways. Inhibitory effects have been described in the case of VDR/RXR heterodimers, where a RXR agonist was a dominant negative retinoic acid receptor RAR␣ blocks granulocytic differentiation at the promyelocyte stage, indicating found to promote the formation of RXR/RXR homodimers at the expense of heterodimers. 18, 19, 34 However, other experithat the RAR␣ subtype may be required successively at an early multipotent progenitor stage and at a later stage of granuments were in favor of transcriptional cooperative effects between VD and 9-cis RA occurring through dual stimulation locytic differentiation. 31 According to our results, the activation of RAR␣ contributes also to VD-induced monocytic difof VDR/RXR heterodimers on VD response elements. 35 , 36 The possibility therefore remains that in U937 cells, RXR ligands ferentiation. It remains to be determined how it is involved in ligands activate both partners of RAR/RXR heterodimers. 40 Up to now, we do not know if the cooperation between VD and retinoids lies mostly on the activation of RAR/RXR, VDR/RXR or perhaps VDR/RAR heterodimers and if it involves the interaction of RXR with yet unidentified orphan receptors. However, it is at least possible to conclude that optimal cooperation between VD and retinoids can be achieved by ligand-dependent activations of both RAR␣ and RXR␣.
